Article

AAO to launch U.S. eye disease patient database

The American Academy of Ophthalmology (AAO) plans to implement the first comprehensive eye disease patient database in the United States.

San Francisco-The American Academy of Ophthalmology (AAO) plans to implement the first comprehensive eye disease patient database in the United States.

The IRIS (Intelligent Research in Sight) Registry is a centralized data repository and reporting tool that collects data from electronic health records and performs statistical analysis of aggregated, de-identified patient data to produce easy-to-interpret, national and practice-level benchmark reports. The reports can validate the quality of care ophthalmologists provide and pinpoint opportunities for improvement. By assessing their quality-of-care rates and studying best practices, ophthalmologists can develop a strategic plan for improving patient outcomes.

The initiative will enable thousands of ophthalmologists across the country to review and analyze their own care statistically and compare it with benchmarks and peer-physician performance.

“This is a fantastically powerful tool that will stimulate improved quality of eye care,” said David W. Parke II, MD, chief executive officer of the AAO. “None of us went to medical school to be average physicians. We respond to data and seek tools to benchmark our own performance.”

The ophthalmology database is expected to provide other significant benefits for eye physicians and surgeons. Top among them is automatic participation in the Physician Quality Reporting System (PQRS). The registry can directly and automatically extract data for PQRS measures and submit it to the Centers for Medicare and Medicaid Services on a practice’s behalf, eliminating the need for the traditional method of ophthalmologists manually reporting their data on their Medicare claims throughout the year.

The AAO envisions that the registry will expand its scope to include functions for completing the American Board of Ophthalmology’s Maintenance of Certification Practice Improvement Modules, clinical research, post-market surveillance studies of ophthalmic drugs and devices, early detection of safety signals for adverse health events and determining changes in practice patterns.

“The [registry] will represent a seminal change in how the medical specialty of ophthalmology will improve performance and outcomes, while shortening the timeline for the dissemination of important clinical knowledge, research and results of drug and device surveillance,” said William L. Rich III, MD, medical director of health policy for the AAO.

For more information, visit www.aao.org/irisregistry or e-mail IRISRegistry@aao.org.

For more articles in this issue of Ophthalmology Times eReport, click here.

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.